Sirion Biotech sirion-biotech.de


Sirion Biotech provides tools and services for functional gene analysis that offers a range of R&D in biotechnology and pharmacentical industry as well as for academia. The company is offering a satisfaction guarantee on gene knockdowns of nearly 100% (RNAiONE), cell lines with built-in reporter genes (SenCELL), next generation cell models with high on-target knockdowns. VariCHECK represents an inducible expression system for the functional analysis of protein variants. Ready-to-use-kits offer u...Show all

Sirion Biotech provides tools and services for functional gene analysis that offers a range of R&D in biotechnology and pharmacentical industry as well as for academia. The company is offering a satisfaction guarantee on gene knockdowns of nearly 100...Show all

Company (Alive / Active)

Phone: +49 89 700 961 99 9

Fax:

Am Klopferspitz 19

Martinsried, D-82152
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sirion Biotech $0M Apr 15, 2013
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sirion Biotech Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Amnis Corporation

Seattle, Washington, United States
AcquiredAmnis Corporation offers high speed cell imaging for research and diagnosticsLogin to see details

HTG Molecular Diagnostics

Tucson, Arizona, United States
IPO / Went publicHTG Molecular Diagnostics provides simple, cost effective solutions for accurate RNA testing. In 2013 the company commercialized its Edge instrument platform and a portfolio of mRNA assays that leverage HTG's proprietary nuclease protection chemistry. The capability of the Edge System has been expanded to fully automate sample and targeted library preparation for next-generation sequencing.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Retroviral transduction using poloxamers Feb 28, 2013 Sep 26, 2017 Patent
Retroviral transduction using poloxamers Sep 22, 2017 Application
Pseudotyped lentiviral vectors Jan 09, 2015 Application
Means and methods to increase adenovirus production Jul 04, 2013 Application